(Q53876804)

21 May 2018

title

The FOXC2 C-512T polymorphism is associated with obesity and dyslipidemia. (English)

1 reference

21 May 2018

0 references

1 reference

4

Leif Groop

1 reference

21 May 2018

2

Peter Almgren

1 reference

21 May 2018

Martin Ridderstråle

series ordinal

5

object named as

Martin Ridderstråle

1 reference

21 May 2018

Emma Carlsson

series ordinal

1

object named as

Emma Carlsson

1 reference

21 May 2018

author name string

Johan Hoffstedt

series ordinal

3

1 reference

21 May 2018

publication date

1 November 2004

1 reference

21 May 2018

published in

Obesity

1 reference

21 May 2018

volume

12

1 reference

21 May 2018

issue

11

1 reference

21 May 2018

page(s)

1738-1743

1 reference

21 May 2018

FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

FOXC2 mRNA Expression and a 5' untranslated region polymorphism of the gene are associated with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

Genetic variation in the human winged helix/forkhead transcription factor gene FOXC2 in Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

Systematic search for single nucleotide polymorphisms in the FOXC2 gene: the absence of evidence for the association of three frequent single nucleotide polymorphisms and four common haplotypes with Japanese type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

The FOXC2 -512C>T variant is associated with hypertriglyceridaemia and increased serum C-peptide in Danish Caucasian glucose-tolerant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

Reduced Expression of FOXC2 and Brown Adipogenic Genes in Human Subjects with Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

The dysmetabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

Combined analysis of genome scans of dutch and finnish families reveals a susceptibility locus for high-density lipoprotein cholesterol on chromosome 16q

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

Allelic Variation in Human Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

Cardiovascular morbidity and mortality associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

Genetics of insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.215

31 March 2020

Identifiers

DOI

10.1038/OBY.2004.215

1 reference

21 May 2018

1 reference

21 May 2018